Associated Papers
Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic BRCA1 Variant in Ovarian Cancer Cases Clinically Negative for Pathogenic BRCA1 and BRCA2 Variants.
Alenezi WM et al.
Genes, 2022
35456503 (PubMed )
Supplement: genes-13-00697-s001.zip › genes-1650796-supplementary.xlsx › Suppl_Table_S3
BRCA1 and BRCA2 common mutations in iranian breast cancer patients: a meta analysis.
Forat-Yazdi M et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2015
A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.
Karami F et al.
Biomed Research International, 2013
Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients.
Konstantopoulou I et al.
Breast Cancer Research and Treatment, 2008
BRCA1 mutation analysis in breast/ovarian cancer families from Greece.
Konstantopoulou I et al.
Human Mutation, 2000
Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors.
Tworek H et al.
Cancer Genetics and Cytogenetics, 1999
Select a paper to view details